4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Wednesday, June 11th, 2025, at 9:20 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations. About Teladoc HealthTeladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses propri

NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees. Effective June 1, 2025, in connection with commencing employment, two new non-executive employees of Teladoc Health were granted awards of restricted stock units covering an aggregate of 80,000 shares of Teladoc Health's common stock, par value $0.001 per share. The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The awards were approv

USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 6, 2025 /PRNewswire/ -- Healthcare is quickly evolving into a digital-first operation, where top executives in the sector are doubling down on artificial intelligence, automation and analytics to reduce costs and improve billing accuracy. This is according to results of a survey from Everest Group (and supported by Omega Healthcare), which showed 85% of senior healthcare executives believe AI will improve efficiencies over the next five years. Now that multitasking AI Agents are being referred to as hospitals' newest "employees", AI-powered electronic noses are detecting scents for health and enviro

PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees. Effective April 30, 2025, in connection with the acquisition of Uplift Health Technologies, Inc., four employees of Uplift Health were granted awards of restricted stock units covering an aggregate of 215,028 shares of Teladoc Health's common stock, par value $0.001 per share ("Common Stock"). The restricted stock units vest, based on continued service to Teladoc Health, over two or three years. Also, effective May 1, 2025, in connection with commencing employment, an additional new non-executive empl

PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 ("First Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 ("First Quarter 2024"). First Quarter 2025 Highlights First Quarter 2025 revenue of $629.4 million, down 3% year-over-yearFirst Quarter 2025 net loss of $93.0 million, or $0.53 per share, including a pre-tax goodwill impairment charge of $59.1 million, or $0.34 per share, which occurred after the issuance of the previously provided outlook and was not included First Qu

PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced it has acquired UpLift, an innovative and tech-enabled provider of virtual mental health therapy, psychiatry and medication management services.    The acquisition supports the company's strategy to further enhance its leadership position in virtual mental health, including the ability for consumers served by its BetterHelp segment to access benefits coverage for mental health services. UpLift serves the health plan market and has arrangements covering over 100 million lives, a network of over 1,500 mental health professionals, important capabilities and a talent

PURCHASE, NY, April 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release first quarter 2025 results on Wednesday, April 30, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 309585. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=81196. A live audio webcast will also be available online at h

PURCHASE, NY, April 08, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today introduced its next generation Cardiometabolic Health Program to improve population health and prevent the progression of diabetes, hypertension and obesity. Building on the company's industry-leading chronic condition management programs, the new offering is designed to support optimal cardiometabolic health for all populations. The program drives healthier behaviors by targeting fundamental measures of cardiometabolic health: diet, physical activity, sleep, stress management, weight, blood lipids, blood glucose, blood pressure and nicotine exposure. These behaviors and h

The partnership enables Teladoc Health's employer clients and members more streamlined and fully integrated access to Carrum's value-based Centers of Excellence network for specialty care SAN FRANCISCO, March 13, 2025 /PRNewswire/ -- Carrum Health, the leader in value-based Centers of Excellence (COE) for specialty care, today announced a strategic partnership with Teladoc Health (NYSE:TDOC), the global leader in virtual care. The new arrangement will allow Teladoc Health's providers to seamlessly refer eligible members needing specialty care into Carrum's nationwide network of rigorously vetted, high quality providers. This means employers can contract directly through Teladoc Health's Conn

CHICAGO, March 12, 2025 (GLOBE NEWSWIRE) -- Cylinder, the leading virtual digestive health provider, today announced its partnership with Teladoc Health (NYSE:TDOC), the global leader in virtual care, to expand access to high-quality, personalized gastrointestinal care. Through this collaboration, Teladoc Health's health plan and employer customers can easily provide members access to Cylinder's evidence-based digestive health platform, through streamlined administrative services and integration enablement. Digestive health conditions affect up to 70 million Americans and drive significant healthcare costs — up to $136 billion annually. Cylinder's platform delivers precise diagnoses and p

144 - Teladoc Health, Inc. (0001477449) (Subject)

SD - Teladoc Health, Inc. (0001477449) (Filer)

8-K - Teladoc Health, Inc. (0001477449) (Filer)

SCHEDULE 13G - Teladoc Health, Inc. (0001477449) (Subject)

DEFA14A - Teladoc Health, Inc. (0001477449) (Filer)

10-Q - Teladoc Health, Inc. (0001477449) (Filer)

8-K - Teladoc Health, Inc. (0001477449) (Filer)

DEFA14A - Teladoc Health, Inc. (0001477449) (Filer)

DEF 14A - Teladoc Health, Inc. (0001477449) (Filer)

144 - Teladoc Health, Inc. (0001477449) (Subject)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

Goldman initiated coverage of Teladoc with a rating of Buy and set a new price target of $14.00

Jefferies reiterated coverage of Teladoc with a rating of Hold and set a new price target of $10.00 from $8.00 previously

Cantor Fitzgerald initiated coverage of Teladoc with a rating of Overweight and set a new price target of $22.00

Leerink Partners initiated coverage of Teladoc with a rating of Market Perform and set a new price target of $17.00

DA Davidson downgraded Teladoc from Buy to Neutral and set a new price target of $22.00 from $33.00 previously

Barclays initiated coverage of Teladoc with a rating of Overweight and set a new price target of $26.00

Stephens initiated coverage of Teladoc with a rating of Equal-Weight and set a new price target of $25.00

SVB Securities upgraded Teladoc from Market Perform to Outperform and set a new price target of $34.00

Guggenheim upgraded Teladoc from Sell to Neutral

KeyBanc Capital Markets initiated coverage of Teladoc with a rating of Sector Weight